SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

InvestoGain Australia

Celebrating 20 Years in Business

Thank you for being part of our development since September 2001. With your ongoing support we look forward to many exciting developments ahead.

SEARCH LISTED COMPANY


Any AUS or NZ company

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

OVENTUS MEDICAL LIMITED(OVN)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of OVN: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare Communication Services, 117 Victoria St, West End QLD 4101

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 7 3237 2152
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000OVN3
Address: 1 Swann Road, Indooroopilly QLD 4068
Tel:  1300 783 639 Fax: 

Date first listed: 19/07/2016
Company Secretary: Stephen Denaro
Sector: Health Care Equipment & Services Industry Group: 
Activities: Oventus Medical Limited develops oral devices for the therapeutic treatment of breathing disorders especially sleep apnoea

News & Events

Expand this box to read and print

The suspension of trading in the securities of Oventus Medical Limited will be lifted immediately, following the release by OVN of an announcement regarding its capital raising.

10/05/2021

The company releases a notice of Proposed issue of Securities.

10/05/2021

The company releases a prospectus for a non-renounceable pro rata offer of 1 fully paid ordinary share in the company for every 4.4 shares held by shareholders registered at 5.00pm (AEST) on 18 May 2021 at an offer price of $0.12 per new share with one free attaching option exercisable at $0.24 each on or before the day that is 24 months after the date of issue for every two new shares issued.

10/05/2021

Firm commitments received for a two tranche Placement reflecting strong support from existing and new institutional and sophisticated investors to raise approximately $5 million. A fully underwritten 1 for 4.4 pro-rata non-renounceable Entitlement Offer launched to raise approximately $5 million to acquire shares at the same price as the placement. Investors who participate in the Placement and Entitlement Offer will receive a free attaching unquoted option on a 1-for-2 basis, exercisable at $0.24 and expiring 2 years from date of issue. Funds strengthen the balance sheet and enable Oventus to enhance its manufacturing operations and logistics and to support one-off restructuring and formation costs.

10/05/2021

The securities of Oventus Medical Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of OVN, pending the release of an announcement regarding its capital raising.

07/05/2021

The suspension of trading in the securities of Oventus Medical Limited will be lifted from the commencement of trading on Tuesday, 24 September 2019, following receipt of a response to an ASX Price Query.

24/09/2019

The company issues a response to ASX Price Query.

24/09/2019

The securities of Oventus Medical Limited will be suspended from quotation immediately under Listing Rule 17.3, following ASX raising a price query with OVN. The securities will remain suspended until a sufficient response to ASX's price query letter has been received.

23/09/2019

listed entity carried for record purposes only

19/07/2016
OFX Transferring Money Internationally to Free

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    13/10/2021Melvyn Bridges82,877$0.120$9,945
    22/09/2021Melvyn Bridges1,300,000$0.111$144,772
    10/09/2021Sue MacLeman86,956$0.117$10,126
    25/03/2020Melvyn Bridges104,687$0.190$19,891
    25/03/2020Sue MacLeman10,685$0.199$2,130

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Sue MacLemanNon Exec Chairman19/07/2016
    John CoxPresident, COO04/06/2021
    Christopher HartManaging Director, CEO19/07/2016
    Sharad JoshiNon Exec Director17/12/2018
    Melvyn BridgesNon Exec Director19/07/2016
    Paul MolloyNon Exec Director16/12/2019
    Jake NunnNon Exec Director25/02/2020

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Neil AndersonExecutive Director19/07/201616/12/2019

    Date of first appointment, title may have changed.